September Monthly Meeting


WHEN: Wednesday, September 13, 2017
WHERE: Duquesne University
RSVP BY: Friday, September 8 at Noon

Dinner reservations are no longer being accepted.

[space height=”10″]


    5:30 PM Technology Forum Speaker’s Presentation: Power Center Ballroom Section C
    5:30 PM Social Hour: Power Center Fides Shepperson Suite
    6:30 PM Dinner: Power Center Ballroom Section C
    8:00 PM Business Meeting: Power Center Ballroom Section C
    8:15 PM Technical Program Speaker’s Presentation: Power Center Ballroom Section C

TECHNOLOGY FORUM – 5:30 PM
Russell L. Cersosimo Jr., Founder, Pennsylvania Medical Cannabis Society (PAMCS), Owner, Keystone Integrated Care

“Pennsylvania Gets The “Green” Light: Insight into the State’s Emerging Medical Cannabis Industry
Dispensaries and grower/processors have received the “green” light to start operating in Pennsylvania, but where does this emerging industry go from here?

Russ Cersosimo, co-founder of the Pennsylvania Medical Cannabis Society (PAMCS) and co-owner Keystone Integrated Care, a newly formed dispensary group that will be operating multiple locations in southwestern Pennsylvania, will provide detailed insight into the medical cannabis industry now that it is legal in the Commonwealth. Cersosimo will provide a “state of the industry” outlining:

  • The evolution of cannabis for medicinal uses
  • What medicinal cannabis means for the state of Pennsylvania
  • Requirements and methods for rollout to both physicians and patients
  • Regulations and standards to ensure patient safety

[space height=”10″]

Cersosimo will shed light on all of the myths and preconceived notions that you might have about cannabis, as well as address any burning questions from attendees in the audience. …READ BIO


TECHNOLOGY PROGRAM – 8:15 PM
Dr. Bhavya Sharma, Assistant Professor / Department of Chemistry University of Tennessee at Knoxville

“Raman Spectroscopy for ViVo Neurochemical Detection”
Many neurological diseases are difficult to diagnose in the early stages of disease progression where treatment would be most beneficial. For various diseases, changes in neurotransmitter concentrations indicate the onset or progression of the disease. Neurotransmitters can also be detected in biofluids, however this involves long sample processing and measurement times. There is a need for the development of sensors for the detection of neurotransmitters in a selective, rapid, label-free, non-invasive manner with little to no sample processing. Our group focuses on the detection of biomarkers for neurological activity in non-invasively collected biofluids and through the skull using surface enhanced Raman spectroscopy (SERS) combined with spatially offset Raman spectroscopy (SESORS). I will present results on the SERS detection of neurotransmitters in the micromolar (μM) to nanomolar (nM) concentration range in aqueous solution and SESORS measurements of neurotransmitters through a skull. …READ BIO